Al Borg Laboratory Home About Us Contact Us
Arabic Version
About Al Borg Labs
Branches
Organogram
Staff
Equipment
Bar Code
Test Menu
Patient Results
Jobs
Training Courses
Health Tips
Newsletters
Related Links
Contact Us
Arabic Version

Al Borg Technical Newsletters
THYROID DISEASE 12/06/2003

Thyroid Disease

 

The American Thyroid Association and the American Association of Clinical Endocrinology

recommend the following:

  • Free T4 and TSH (3rd generation) are reliable tests in diagnosing
     A thyroid dysfunction.
  • Adults should be screened for thyroid disease beginning at age 35
    and every 5 years thereafter.
  • All women considering pregnancy should be tested.
  • All pregnant women with normal thyroid functions and high anti-TPO
    are at risk of  subsequent clinical hypothyroidism(50%-80% chance).

Thyroid disease is a common condition with adverse multisystem effects.

The  Incidence of  the disease increases with age and women are 8 times more prone
to developing thyroid dysfunction than men.

Postpartum thyroid disease occurs in up to 9% of pregnant women.

Up to 40% of people taking thyroid medication are uncontrolled.


The adverse effects of thyroid disease include;

1) Cardiovascular disease:

            risk of myocardial infarction, elevated serum cholesterol, atherosclerosis

            and atrial fibrillation.

2) Adverse pregnancy outcomes:

            high risk of  fetal death, children with reduced IQ and increased risk

            of postpartum thyroid disease.

3) Mental health:

             depression, increased risk of dementia and Alzheimer’s

             (Clinical Endocrinology 2000;53:733-737)

 

Anti-Thyroid peroxidase antibodies (anti-TPO)

       Thyroid peroxidase is a membrane bound glycoprotein that mediates the oxidation

       of iodide ions and the incorporation of iodine into tyrosine residues of  thyroglobin

Clinical applications of anti-TPO include

Risk factor for auto-immune thyroid disease.

Diagnosis of auto-immune thyroid disease.

Risk factor for post partum thyroiditis.

Risk factor for miscarriage and in vitro fertilisation failure.

TSH receptor antibody applications

Diagnosis and therapy control of Grave’s disease.

Assessing the risk of fetal thyroid problems in mothers with a history of Grave’s
disease.

Hypothyroidism with suspected blocking-type antibodies

Print This Newsletter          Back to Technical Newsletters

Copyright © 2003-2004 Al Borg Laboratory. All Right Reserved